Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Medicover picks up 22...

    Medicover picks up 22 per cent stake in MaxCure Hospitals

    Written by Ruby Khatun Khatun Published On 2017-08-23T11:30:53+05:30  |  Updated On 23 Aug 2017 11:30 AM IST
    Medicover picks up 22 per cent stake in MaxCure Hospitals

    Hyderabad: Hyderabad-based MaxCure Group of Hospitals said European healthcare provider Medicover may pick up 51 per cent stake in it for a total of Rs 320 crore over the next two years.


    Medicover announced here that it has picked up 22 per cent stake in the MaxCure Group of Hospitals by investing Rs 100 crore.


    MaxCure Group of Hospitals Managing Director Dr Anil Krishna said going forward, the Nasdaq-listed Medicover will be investing another Rs 220 crore in MaxCure Hospitals to take their stake to 51 per cent over the next two years.


    "Our aim is to expand pan-India and overseas, and for this, we are partnering with Medicover," Anil Krishna said.


    MaxCure Hospitals had a turnover of Rs 350 crore last fiscal and expect to cross Rs 500 crore turnover in the current fiscal, Anil Krishna said, adding they are now looking at expanding to Bengaluru, Pune, and Chennai.


    MaxCure, with 9 super-specialty hospitals in the states of Telangana and Andhra Pradesh, is a 1600-bed hospital group.


    "Medicovers search for a strategic investment in multi-specialty healthcare received the best start with the acquisition of the stake in the MaxCure group," said Medicover Chairman Fredrik Stenmo.


    "We have invested over USD 100 million in India over the last seven years, and if good opportunities come we are prepared to commit more money," Fredrik said.


    MaxCure Hospitals CEO Hari Krishna said they plan to have a total of 3,500 to 4,000 beds and 18 to 20 hospitals by 2019.


    Two directors from Medicover have been nominated to the MaxCure board.


    Medicover was established in Poland in 1995 and its largest operations are in Germany, the United Kingdom, Poland, Romania and Ukraine.


    This is the second investment of Medicover after it ventured into the Indian healthcare sector last year with the launch of IVF clinics in Delhi.

    22 per cent stakeAndhra PradeshBengaluruChennaiDr Anil KrishnaFredrik StenmoInvestmentMaxCureMaxCure Group of HospitalsMaxCure HospitalsMedicoverpan Indiapicks upPunestakeTelangana
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok